Coherus Bio (CHRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 72,406 | 126,971 | 125,007 | 158,286 | 150,452 |
| Receivables | N/A | N/A | 1,859 | 1,560 | 2,417 |
| Inventories | 1,659 | N/A | N/A | N/A | N/A |
| Other current assets | 2,462 | 3,537 | 34,620 | 37,540 | 26,267 |
| TOTAL | $84,433 | $145,477 | $161,486 | $197,386 | $179,136 |
| Non-Current Assets | |||||
| PPE Net | 6,660 | 12,773 | 10,772 | 10,504 | 4,472 |
| Intangibles | 3,563 | 3,563 | 3,563 | 3,563 | 3,563 |
| Other Non-Current Assets | 4,811 | 798 | 2,664 | 931 | 50 |
| TOTAL | $15,034 | $17,134 | $16,999 | $14,998 | $8,085 |
| Total Assets | $99,467 | $162,611 | $178,485 | $212,384 | $187,221 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 15,294 | 15,714 | 20,583 | 29,496 | 10,798 |
| Accrued Expenses | 17,548 | 9,050 | 28,022 | 24,133 | 11,231 |
| Other current liabilities | 419 | 3,631 | 6,879 | 2,768 | 6,954 |
| TOTAL | $33,261 | $28,395 | $56,376 | $106,018 | $51,783 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | 892 | 49,621 | 22,800 |
| Other Non-Current Liabilities | 104,867 | 103,797 | 102,537 | 68,635 | 28,826 |
| TOTAL | $104,797 | $103,681 | $102,755 | $113,295 | $68,681 |
| Total Liabilities | $138,058 | $132,076 | $159,131 | $219,313 | $120,464 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,260 | 60,142 | 51,147 | 39,103 | 33,324 |
| Common Shares | 7 | 6 | 5 | 4 | 3 |
| Retained earnings | -984,831 | -775,492 | -537,322 | -409,985 | -186,725 |
| Other shareholders' equity | -282 | -2,039 | -1,803 | -1,123 | -569 |
| TOTAL | $-38,591 | $30,535 | $19,354 | $-6,929 | $66,757 |
| Total Liabilities And Equity | $99,467 | $162,611 | $178,485 | $212,384 | $187,221 |